Skip to main content
S 2433 118th Congress Senate Health

SUPPORT for Patients and Communities Reauthorization Act of 2023

Introduced: July 20, 2023 Introduced by: Cassidy, Bill Republican · Louisiana See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 118th Congress ended
It never became law before the 118th Congress (2023–2024) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 20, 2023
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Jul 20, 2023
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

SUPPORT for Patients and Communities Reauthorization Act of 2023

This bill reauthorizes through FY2028 programs and activities relating to mental health and substance use disorder services.

Reauthorized programs and activities include 

  • programs that enable access to drugs or devices that temporarily reverse opioid overdoses,
  • activities to support the capacity of laboratories to detect synthetic opioids (e.g., fentanyl),
  • residential treatment programs for pregnant and postpartum individuals, and
  • training and workforce development for providers of mental health and substance use disorder services.

The bill also modifies certain requirements relating to the regulation of controlled substances and the provision of mental health and substance use disorder services, including by requiring (1) the issuance of federal guidance to support at-home safe disposal systems for drugs, (2) studies to evaluate the efficacy of opioid treatment through buprenorphine and methadone, and (3) evaluations of the use of certain block grants by states to treat individuals with serious mental illnesses.

What's happening now July 20, 2023

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

 Related & companion bills 7
  • HR 3946 Related bill FASD Respect Act
  • HR 4063 Related bill FIND Fentanyl Act of 2023
  • S 1800 Related bill FASD Respect Act
  • HR 5598 Related bill TREAT Youth Act
  • S 3070 Related bill Youth Prevention and Recovery Reauthorization Act of 2023
  • S 3370 Related bill Promoting Maternal and Child Health Through Substance Use Prevention Act
  • HR 7899 Related bill To direct the Attorney General, in consultation with the Secretary of Health and Human Services, to promulgate the fina…
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
Cite this page click to expand
APA
U.S. Congress. (2026). S. 2433: SUPPORT for Patients and Communities Reauthorization Act of 2023. 118th Congress. Open America. https://openamerica.io/bill/118-S-2433/
MLA
"S. 2433: SUPPORT for Patients and Communities Reauthorization Act of 2023." 118th Congress, 2026, Open America, https://openamerica.io/bill/118-S-2433/.
Bluebook (legal)
S. 2433, 118th Cong. (2026), https://openamerica.io/bill/118-S-2433/.
Markdown link
[S. 2433: SUPPORT for Patients and Communities Reauthorization Act of 2023](https://openamerica.io/bill/118-S-2433/)
Report a problem